Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S (Medicine)
Gastroenterologist
MBBS, MCPS (Internal Medicine), FCPS (Gastroenterology & Hepatology), M.A.C.G (USA)
Gastroenterologist
MBBS, MCPS (Internal Medicine), FCPS (Gastroenterology & Hepatology), M.A.C.G (USA)
Diabetologist
MBBS, FRCP (Ed.), FRCP (Glasg.), MRCP (UK), FACP (USA), FACC (USA), FASIM (USA), M.D
Diabetologist
MBBS, FRCP (Ed.), FRCP (Glasg.), MRCP (UK), FACP (USA), FACC (USA), FASIM (USA), M.D
Gastroenterologist
MBBS, MD, MACP, FCPS
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP(UK)
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, FCPS, MRCP (Ireland), MRCP (Glasgow)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures